Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health In Tech (HIT) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Health In Tech (HIT) over the last 3 years, with Q1 2025 value amounting to $54.6 million.

  • Health In Tech's Shares Outstanding (Weighted Average) rose 550.62% to $54.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was $54.6 million, marking a year-over-year increase of 550.62%. This contributed to the annual value of $51.8 million for FY2024, which is 836.53% up from last year.
  • As of Q1 2025, Health In Tech's Shares Outstanding (Weighted Average) stood at $54.6 million, which was up 550.62% from $51.8 million recorded in Q4 2024.
  • Health In Tech's 5-year Shares Outstanding (Weighted Average) high stood at $54.6 million for Q1 2025, and its period low was $47.8 million during Q4 2023.
  • For the 3-year period, Health In Tech's Shares Outstanding (Weighted Average) averaged around $51.5 million, with its median value being $51.8 million (2024).
  • As far as peak fluctuations go, Health In Tech's Shares Outstanding (Weighted Average) skyrocketed by 836.53% in 2024, and later skyrocketed by 550.62% in 2025.
  • Health In Tech's Shares Outstanding (Weighted Average) (Quarter) stood at $47.8 million in 2023, then rose by 8.37% to $51.8 million in 2024, then grew by 5.36% to $54.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $54.6 million in Q1 2025, compared to $51.8 million in Q4 2024 and $51.8 million in Q1 2024.